UCB Showcases Key Rheumatology Data at ACR Convergence 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: UCB) | Delayed: 36.73 -0.39 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.12 | 52 Week High | $ | |||
| Open | $37.24 | 52 Week Low | $ | |||
| Day High | $37.24 | P/E | N/A | |||
| Day Low | $36.46 | EPS | $ | |||
| Volume | 109,952 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 150.31 -0.34 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.65 | 52 Week High | $46.25 | |||
| Open | $148.69 | 52 Week Low | $32.74 | |||
| Day High | $150.50 | P/E | N/A | |||
| Day Low | $148.69 | EPS | $0.00 | |||
| Volume | 7,568 | |||||
